51387-92-9 + 86-98-6 = 86-42-0 反应条件:1.1 Solvents: Ethanol; 24 H,80 °C 标题:The Synthesis Of Amodiaquine Hydrochloride 作者:Nguyen,Van Hung; Et Al 参考文献:Tap Chi Hoa Hoc 日期:2012 卷标:50(2) 页码:174-177]
51387-92-9 + 21617-15-2 = 86-42-0 反应条件:1.1 Reagents: Oxygen Catalysts: Cupric Acetate,Palladium Diacetate,4,4′-Dimethoxy-2,2′-Bipyridine Solvents: Pivalic Acid; 4 - 12 H,140 °C; 140 °C -> Rt1.2 Reagents: Sodium Carbonate Solvents: Water; Rt 标题:Aerobic Dehydrogenative Aromatization In The Preparation Of 4-Aminoquinoline Derivatives By Synergistic Pd/cu Catalysis 作者:Chen,Fei; Et Al 参考文献:Journal Of Organic Chemistry 日期:2023 卷标:88(22) 页码:15589-15596]
21617-14-1 = 86-42-0 反应条件:1.1 6 - 8 H,120 °C; 120 °C -> Rt1.2 Reagents: Water; 0 °C; Overnight,Rt1.3 Reagents: Sodium Carbonate Solvents: Water; Ph 8 - 10,Rt2.1 Reagents: Oxygen Catalysts: Cupric Acetate,Palladium Diacetate,4,4′-Dimethoxy-2,2′-Bipyridine Solvents: Pivalic Acid; 4 - 12 H,140 °C; 140 °C -> Rt2.2 Reagents: Sodium Carbonate Solvents: Water; Rt 标题:Aerobic Dehydrogenative Aromatization In The Preparation Of 4-Aminoquinoline Derivatives By Synergistic Pd/cu Catalysis 作者:Chen,Fei; Et Al 参考文献:Journal Of Organic Chemistry 日期:2023 卷标:88(22) 页码:15589-15596]
103-90-2 = 86-42-0 反应条件:1.1 Solvents: Ethanol; 4.5 H,80 - 90 °C1.2 Reagents: Sodium Carbonate Solvents: Water; Neutralized2.1 Reagents: Hydrochloric Acid Solvents: Ethanol; 2 H,100 - 110 °C2.2 Reagents: Sodium Carbonate Solvents: Water; Neutralized3.1 Solvents: Ethanol; 24 H,80 °C 标题:The Synthesis Of Amodiaquine Hydrochloride 作者:Nguyen,Van Hung; Et Al 参考文献:Tap Chi Hoa Hoc 日期:2012 卷标:50(2) 页码:174-177]
专利号:WO-2013138200-A1 优先权日:2012-03-13 标 题 :Green chemistry synthesis of the malaria drug amodiaquine and analogs thereof 发明人:FORTUNAK JOSEPH MARIAN; KULKARNI AMOL ANANT; KING CHRISTOPHER 权利人:UNIV HOWARD 摘要:Methods are provided for a green chemistry one-pot synthesis of amodiaquine and amodiaquine analogs. The methods have a lower environmental impact, lower investment cost, reduced amounts of byproducts and impurities, and a shorter synthesis time, compared to current conventional synthesis methods. The methods reduce the total number of steps in the synthesis from four to five down to two, thereby simplifying production; and allow a reduced number of solvents and reagents to be used in production, thereby reducing the waste generated in the synthesis. The methods can reduce the waste to about 3-5 kilograms of waste generated per kilogram of product produced; and surprisingly improve the overall yield from 60-65% to greater than 90% as compared to the current conventional synthesis methods for amodiaquine and its analogs.
专利号:US-2012100555-A1 优先权日:2009-06-29 标题 :Synthesis And Use Of Fluorophore-Tagged Antimalarials 发明人:LEAR MARTIN JAMES; TAN KEVIN SHYONG WEI 权利人:LEAR MARTIN JAMES; TAN KEVIN SHYONG WEI 摘要:This invention includes a fluorophore-tagged antimalarial represented by the following structural formula (1) or a salt thereof. This invention relates to the synthesis of fluorophore-tagged antimalarials and describes the synthesis of a fluorophore-tagged antimalarial. These fluorophore-tagged antimalarials can be used to image live cells to determine the location of the antimalarial in the cell, identify drug resistance and growth related pathways in Plasmodium isolates, identify new drug targets and chemo-sensitizers to reverse drug resistance.
专利号:US-9409879-B2 优先权日:2011-03-29 标 题 :Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents 发明人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA 权利人:DAVIOUD-CHARVET ELISABETH; LANFRANCHI DON ANTOINE; JOHANN LAURE; WILLIAMS DAVID LEE; CESAR RODO ELENA; CENTRE NAT RECH SCIENT 摘要:Naphthoquinones, azanaphthoquinones and benxanthones, their process of synthesis and methods of their use as antimalarial or antischistosomal agents.
专利号:US-7427483-B2 优先权日:2006-02-24 标题:Utilization of nucleotide probes in ELISA procedure for the quantitative determination of Plasmodium falciparum DNA in malaria 发明人:NGUYEN KHUE VU 权利人:VISTA BIOLOG CORP 摘要:The present invention is the development of a simple and specific quantitative method for the determination of P. falciparum DNA in malaria that involves the direct detection of the highly 42-kDa conserved C-terminal region of P. falciparum merozoite surface protein (MSP1) gene. This procedure entails the amplification of the 42-kDa C-terminal region of the MSP1 gene by using the PCR technique in the presence of digoxigenin-11-dUTP and the synthesis of the specific biotin labeled nucleotide probes directed to the 42-kDa C-terminal region of the MSP1 gene. These specific probes are then used in the Enzyme Linked Immunosorbent Assay (ELISA) for the quantitative determination of the 42-kDa C-terminal region of the MSP1 gene which leads to the quantitative determination of P. falciparum DNA in malaria for quantitative diagnostic purpose as well as for monitoring the efficacy of antimalarial treatment.
专利号:WO-2023187827-A1 优先权日:2022-03-30 标题:A pharmaceutical composition comprising an inhibitor of glutamine synthetase enzyme to combat artemisinin resistance in malaria 发明人:ARUN NAGARAJ VISWANATHAN; PADMANABAN GOVINDARAJAN; GHOSH SOURAV; KUNDU RAJIB; CHANDANA MANJUNATHA; ANAND ADITYA 权利人:INST OF LIFE SCIENCES 摘要:The present disclosure relates to a pharmaceutical composition to combat artemisinin resistance in malaria with the identification of Plasmodium falciparum (Pf) glutamine synthetase (GS) as a drug target. Pf Gs is important for maintaining asparagine levels in the parasite and promote protein synthesis. Since ART-resistant parasites undergo fitness loss in amino acid/nutrient- limiting conditions and GS levels are upregulated during ART exposure, targeting Pf GS and asparagine requirement can be harnessed to prevent ART resistance. The present disclosure also provides a method of suppressing the growth of Plasmodium falciparum and a method of treating malaria using GS inhibitors.
专利号:US-10550127-B1 优先权日:2017-02-08 标题:Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes 发明人:ECKHARDT MATTHIAS; WAGNER HOLGER; PETERS STEFAN 权利人:BOEHRINGER INGELHEIM INT 摘要:The present invention relates to compounds of general formula I, n nwherein the groups R, R 1 , R 2 , m and n are defined herein, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
1: Gil JP. Amodiaquine pharmacogenetics. Pharmacogenomics. 2008 Oct;9(10):1385-90. doi: 10.2217/14622416.9.10.1385. (2):CD000016. doi: 10.1002/14651858.CD000016. Update in: Cochrane Database Syst Rev. 2003;(2):CD000016. (2):CD000016. doi: 10.1002/14651858.CD000016. 348(9042):1659-60. doi: 10.1016/S0140-6736(05)65723-6. 16(7):1079-85. doi: 10.1517/13543784.16.7.1079. 1(9):298-9. doi: 10.5694/j.1326-5377.1977.tb130706.x. 348(9036):1196-201. doi: 10.1016/S0140-6736(96)06217-4. 4(12):721-2; discussion 722. doi: 10.1016/S1473-3099(04)01198-3. (4):CD000386. doi: 10.1002/14651858.CD000386. Update in: Cochrane Database Syst Rev. 2005;(4):CD000386. (2):CD000386. doi: 10.1002/14651858.CD000386. Update in: Cochrane Database Syst Rev. 2001;(4):CD000386. 6(6):631-5. doi: 10.1517/14740338.6.6.631. 2(6029):214-5. doi: 10.1136/bmj.2.6029.214. 13: Sakurai Y, Sakakibara N, Toyama M, Baba M, Davey RA. Novel amodiaquine derivatives potently inhibit Ebola virus infection. Antiviral Res. 2018 Dec;160:175-182. doi: 10.1016/j.antiviral.2018.10.025. Epub 2018 Nov 3. 14: Willems S, Müller M, Ohrndorf J, Heering J, Proschak E, Merk D. Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries. ChemMedChem. 2022 Apr 20;17(8):e202200026. doi: 10.1002/cmdc.202200026. Epub 2022 Feb 21.
合成参考文献
参考文献:10.1186/1475-2875-9-53 摘要:Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, Okuboyejo TM, Michael OS. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malaria Journal. 2010 Feb 15;9(1):53. doi: 10.1186/1475-2875-9-53. 参考文献:10.1186/1475-2875-10-187 摘要:Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Osei JH, Asahi H, Ofori MF, Akao N, Wilson MD, Boakye DA, Ohta N. Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malaria Journal. 2011 Jul 11;10(1):187. doi: 10.1186/1475-2875-10-187. 参考文献:10.1186/1475-2875-4-56 摘要:Helleberg M, Goka BQ, Akanmori BD, Obeng-Adjei G, Rodriques O, Kurtzhals JA. Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia. Malaria Journal. 2005 Dec 01;4(1):56. doi: 10.1186/1475-2875-4-56. 参考文献:10.1186/1471-2458-11-573 摘要:Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial. BMC Public Health. 2011 Jul 18;11():573. 参考文献:10.1371/journal.pone.0021237 摘要:Penna-Coutinho J, Cortopassi WA, Oliveira AA, França TCC, Krettli AU. Antimalarial Activity of Potential Inhibitors of Plasmodium falciparum Lactate Dehydrogenase Enzyme Selected by Docking Studies. PLoS ONE. 2011 Jul 14;6(7):e21237. doi: 10.1371/journal.pone.0021237.